Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study - Archive ouverte HAL Access content directly
Journal Articles Annals of Oncology Year : 2018

Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study

R. Sabatier
CV
C. Pomel
  • Function : Author
P-E. Colombo
  • Function : Author
F. Narducci
  • Function : Author
S. Garnier
  • Function : Author
Centre de Recherche en Cancérologie de Marseille
N. Carbuccia
  • Function : Author
A. Guille
  • Function : Author
Centre de Recherche en Cancérologie de Marseille
D. Birnbaum
  • Function : Author
Centre de Recherche en Cancérologie de Marseille
C. Zemmour
  • Function : Author
E. Lambaudie
  • Function : Author
Centre de Recherche en Cancérologie de Marseille

Domains

Life Sciences [q-bio]

Ghislain Bidaut  : Connect in order to contact the contributor

https://hal-amu.archives-ouvertes.fr/hal-02143654

Submitted on : Wednesday, May 29, 2019-2:52:17 PM

Last modification on : Friday, March 24, 2023-2:53:11 PM

Consult the full text

Dates and versions

hal-02143654 , version 1 (29-05-2019)

Identifiers

Cite

R. Sabatier, C. Pomel, P-E. Colombo, F. Narducci, S. Garnier, et al.. Circulating tumour DNA as an early marker of recurrence and treatment efficacy in ovarian carcinoma, the CIDOC study. Annals of Oncology, 2018, 29 (6), pp.3. ⟨10.1093/annonc/mdy316.007⟩. ⟨hal-02143654⟩

Export

BibTeX TEI Dublin Core DC Terms EndNote Datacite

Collections

CNRS UNIV-AMU CRCM
9 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More